183 filings
Page 6 of 10
8-K
yo57w2whg
4 Mar 09
Other Events
12:00am
CORRESP
34ek a5zid
26 Feb 09
Correspondence with SEC
12:00am
CT ORDER
v9zoq k2b1
19 Feb 09
Confidential treatment order
12:00am
UPLOAD
9u7 b53zw82p
5 Feb 09
Letter from SEC
12:00am
CORRESP
lv0rxn
4 Feb 09
Correspondence with SEC
12:00am
8-K/A
x24i5vs215f4p6t74 qe
4 Feb 09
Changes in Registrant's Certifying Accountant
12:00am
UPLOAD
zin0y7al5eu4rha8ndem
26 Jan 09
Letter from SEC
12:00am
8-K
zje1k7
23 Jan 09
Changes in Registrant.s Certifying Accountant
12:00am
8-K
kxl656szbevs7k4
9 Jan 09
Termination of a Material Definitive Agreement
12:00am
8-K
ybfy58gi
8 Jan 09
Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications
12:00am
CT ORDER
m74t2jpv
5 Jan 09
Confidential treatment order
12:00am
8-K
ze78k
26 Nov 08
Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
12:00am
10-Q
o3o9 6i7pfvly
19 Nov 08
Quarterly report
12:00am
NT 10-Q
cty5l1mdq40z0hhahw
13 Nov 08
Notice of late quarterly filing
12:00am
8-K
e46s0bx7 3ivapz8ml9
13 Nov 08
Intellect Neurosciences, Inc. Validates Pivotal European Patent for Alzheimer's Monoclonal Antibody Platform
12:00am
8-K
11vw fngx5
14 Oct 08
Agreement Follows Recent Grant by Intellect of License to Wyeth
12:00am
NT 10-K
it5aonjhp8vwirpdecq3
29 Sep 08
Notice of late annual filing
12:00am
8-K
99q1c0
4 Aug 08
Intellect Neurosciences, Inc. Obtains Pivotal European Patent Related To Monoclonal Antibody Passive Immunization Treatment Of Alzheimer's Disease
12:00am
8-K
i51qcjhn nehdnqphc
30 Jun 08
Triggering Events That Accelerate or Increase a Direct Financial Obligation under an Off-Balance Sheet Arrangement
12:00am